Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
INPHI Corp (IPHI)
|
Add to portfolio |
|
|
|
| Price: |
$178.73
| | Metrics |
| OS: |
53.7
|
M
| |
-17
|
% ROE
|
| Market cap: |
$9.59
|
B
| |
-4
|
% ROIC
|
|
Net debt:
|
$297
|
M
| |
2.7
|
x Debt/EBITDA
|
|
EV:
|
$9.89
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$111
|
M
| |
89.2
|
x EV/EBITDA
|
|
EBIT
|
($16.8)
|
M
| |
|
|
| EPS |
($1.24)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 683.0 | 365.6 | 294.5 | 348.2 | 266.3 | 192.7 | 96.1 | 102.7 |
| Revenue growth | 86.8% | 24.2% | -15.4% | 30.8% | 38.2% | 100.4% | -6.3% | 12.6% |
| Cost of goods sold | 311.8 | 152.8 | 129.3 | 151.7 | 85.6 | 72.7 | 44.2 | 37.1 |
| Gross profit | 371.1 | 212.8 | 165.1 | 196.5 | 180.7 | 120.0 | 51.9 | 65.6 |
| Gross margin | 54.3% | 58.2% | 56.1% | 56.4% | 67.9% | 62.3% | 54.0% | 63.9% |
| Sales and marketing | 61.3 | 47.7 | 43.1 | 42.4 | 26.5 | 21.5 | 15.1 | 15.7 |
| Research and development | 269.1 | 183.9 | 167.9 | 200.5 | 108.0 | 87.8 | 56.5 | 50.5 |
| General and administrative | 57.5 | 30.7 | 28.3 | 23.8 | 21.2 | 20.3 | 16.2 | 11.6 |
| EBITA | 74.9 | 20.1 | -11.7 | -13.0 | 117.7 | 3.2 | -32.7 | -12.3 |
| EBITA margin | 11.0% | 5.5% | -4.0% | -3.7% | 44.2% | 1.7% | -34.0% | -12.0% |
| Amortization of intangibles | 91.7 | 69.6 | 62.5 | 57.2 | 14.2 | 12.7 | 3.2 | |
| EBIT | -16.8 | -49.4 | -74.2 | -70.2 | 103.5 | -9.5 | -35.9 | -12.3 |
| EBIT margin | -2.5% | -13.5% | -25.2% | -20.2% | 38.9% | -5.0% | -37.3% | -12.0% |
| Pre-tax income | -55.3 | -72.5 | -104.0 | -96.1 | 11.5 | -10.1 | -35.4 | -11.4 |
| Income taxes | 4.5 | 0.4 | -8.2 | -21.2 | -15.1 | 5.9 | 1.1 | 1.8 |
| Tax rate | | | 7.9% | 22.0% | | | | |
| Net income | -59.7 | -72.9 | -95.8 | -74.9 | 99.5 | -13.6 | -22.6 | -13.2 |
| Net margin | -8.7% | -19.9% | -32.5% | -21.5% | 37.4% | -7.0% | -23.5% | -12.8% |
| |
| Diluted EPS | ($1.20) | ($1.61) | ($2.19) | ($1.78) | $0.60 | ($0.41) | ($1.12) | ($0.45) |
| Shares outstanding (diluted) | 49.9 | 45.2 | 43.7 | 42.2 | 44.1 | 38.6 | 32.7 | 29.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|